ID: ALA1939728

Max Phase: Preclinical

Molecular Formula: C38H62I2N14O8

Molecular Weight: 843.00

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[N+](C)(CCCC(=O)NCCCCCCNC(=O)CCC[N+](C)(C)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O.[I-].[I-]

Standard InChI:  InChI=1S/C38H60N14O8.2HI/c1-51(2,17-23-29(55)31(57)37(59-23)49-21-47-27-33(39)43-19-45-35(27)49)15-9-11-25(53)41-13-7-5-6-8-14-42-26(54)12-10-16-52(3,4)18-24-30(56)32(58)38(60-24)50-22-48-28-34(40)44-20-46-36(28)50;;/h19-24,29-32,37-38,55-58H,5-18H2,1-4H3,(H4-2,39,40,41,42,43,44,45,46,53,54);2*1H/t23-,24-,29-,30-,31-,32-,37-,38-;;/m1../s1

Standard InChI Key:  KAOTYCNYTUTTQG-SRPCAPLNSA-N

Associated Targets(non-human)

metJ Met repressor (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 843.00Molecular Weight (Monoisotopic): 842.4864AlogP: -1.42#Rotatable Bonds: 21
Polar Surface Area: 296.82Molecular Species: NEUTRALHBA: 18HBD: 8
#RO5 Violations: 3HBA (Lipinski): 22HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.11CX Basic pKa: 5.22CX LogP: -10.95CX LogD: -10.95
Aromatic Rings: 4Heavy Atoms: 60QED Weighted: 0.04Np Likeness Score: 0.26

References

1. Joce C, White R, Stockley PG, Warriner S, Turnbull WB, Nelson A..  (2012)  Design, synthesis and in vitro evaluation of novel bivalent S-adenosylmethionine analogues.,  22  (1): [PMID:22137339] [10.1016/j.bmcl.2011.11.017]

Source